- Office of Research and Sponsored Programs
- Institutional Animal Care and Use Program
- Institutional Review Board
- IRB News & Updates
- Protocol Submission
- Does My Research Require Review?
- Review Categories
- Review Process
- Review Decisions
- Criteria for Approval or Suspension of Research
- Normal Educational Practices Considered Exempt From Full Committee Review
- Protocol Guidelines
- How to Facilitate IRB Protocol Review
- Issues of Special Concern
- Complete Protocol Package
- Elements of Voluntary Informed Consent
- Guidelines for Obtaining Assent from Minors
- Human Subjects Research Training Course
- Forms & Templates
- Modification Review
- Continuation Review
- Adverse Events
- Protocol Deviation/Violation
- Use of Deception in Research
- Frequently Asked Questions
- IRB Membership
- Other Resources
- IRB Membership
- Understanding Reliance Agreements
- Policy Library
- Forms Library
- Centers and Institutes at CSUEB
- Monitoring Tools
Criteria for Approval or Suspension of Research
From the Code of Federal Regulations, title 45 part 46
46.111 Criteria for IRB approval of research.
- In order to approve research covered by this policy the IRB shall determine that all of the following requirements are satisfied:
- Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes.
- Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility.
- Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons.
- Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by §46.116.
- Informed consent will be appropriately documented, in accordance with, and to the extent required by §46.117.
- When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects.
- When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.
§46.112 Review by institution.
Research covered by this policy that has been approved by an IRB may be subject to further appropriate review and approval or disapproval by officials of the institution. However, those officials may not approve the research if it has not been approved by an IRB.
Criteria for Suspension of Research
§46.113 Suspension or termination of IRB approval of research.
An IRB shall have authority to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated with unexpected serious harm to subjects. Any suspension or termination of approval shall include a statement of the reasons for the IRB's action and shall be reported promptly to the investigator, appropriate institutional officials, and the department or agency head.